Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV001703750 | SCV000523092 | benign | not provided | 2020-09-23 | criteria provided, single submitter | clinical testing | |
Invitae | RCV000528289 | SCV000654346 | likely benign | Developmental and epileptic encephalopathy 94 | 2024-01-24 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002318421 | SCV000850886 | likely benign | Inborn genetic diseases | 2017-12-27 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Revvity Omics, |
RCV000528289 | SCV003831916 | uncertain significance | Developmental and epileptic encephalopathy 94 | 2019-01-18 | criteria provided, single submitter | clinical testing | |
Ce |
RCV001703750 | SCV004130951 | likely benign | not provided | 2022-09-01 | criteria provided, single submitter | clinical testing | CHD2: BS2 |
Prevention |
RCV003959906 | SCV004773977 | likely benign | CHD2-related condition | 2021-07-13 | criteria provided, single submitter | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |